Common Stock
- Symbol
- TECH
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Bio-Techne Corp
TECHNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events A copy of the press release issued by Bio-Techne Corporation on November 3, 2026, announcing a cash dividend is attached hereto as Exhibit 99.1.
Press release in this filing
BIO-TECHNE DECLARES DIVIDEND →Company context
Bio Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer focused brands: R&D Systems™, Bio Techne Spatial™, and Bio Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision making. Bio Techne operates in 34 locations worldwide and employs more than 3,000 people. In fiscal year 2025, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.
Current securities
Registered securities in this filing
BIO-TECHNE CORPORATION · 8-K · Filed 2026-11-04
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events
A copy of the press release issued by Bio-Techne Corporation on November 3, 2026, announcing a cash dividend is attached hereto as Exhibit 99.1.
Filed exhibits (1)
Exhibit 99.1 BIO-TECHNE DECLARES DIVIDEND MINNEAPOLIS, November 3, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarterly dividend will be payable November 23, 2026, to all common shareholders of record at the close of business on November 13, 2026, provided Bio-Techne’s previously announced transaction with Merck KGaA, Darmstadt, Germany has not closed on or before the close of business on November 13, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis, as applicable. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2026 and has approxima…
Open exhibit ↗